论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Zhu Y, Cao X, Zhang X, Chen Q, Wen L, Wang P
Received 22 September 2018
Accepted for publication 16 December 2018
Published 12 February 2019 Volume 2019:11 Pages 1383—1390
DOI https://doi.org/10.2147/CMAR.S188415
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 1
Editor who approved publication: Professor Nakshatri
Purpose: To study
the prognostic value of klotho (KL) and its promoter DNA methylation in
head and neck squamous cell carcinoma (HNSCC) and to assess their associations
with the autophagy gene LC3 and the RNA transferase gene NSUN2.
Materials and methods: Upper
quartile normalized RNA-seq V2 RSEM values of KL mRNA and beta value for KL
methylation were retrieved from The Cancer Genome Atlas HNSCC dataset.
Kaplan–Meier survival curves were used to assess the associations of KL
expression and methylation with patient survival; multivariate Cox proportional
hazards regression models were used to estimate the HRs and their 95% CIs.
Results: There is
a negative relationship between KL gene expression and its promoter DNA
methylation in HNSCC. KL gene expression was positively correlated with overall
survival, while KL methylation was inversely correlated with the overall
survival of HNSCC patients. Furthermore, KL methylation was significantly
associated with gender (P =0.012), tumor grade (P =0.0009) and tumor
site (P <0.0001).
Finally, HNSCC patients with high KL gene expression or low KL DNA methylation
had high LC3 but low NSUN2.
Conclusion: KL
methylation silenced its gene expression in HNSCC. Low KL expression and high
KL methylation can be potential biomarkers for worse prognosis in HNSCC. As the
downstream targets, LC3 and NSUN2 could be responsible for the KL expression
in HNSCC.
Keywords: biomarkers,
gene silencing, head neoplasms, neck neoplasms, predictive values, prognosis